Eric di Luccio (0000-0002-2256-2157)

Personal information

Biography

Executive Officer, Chief Technology Officer (CTO), Head of R&D center at Hirotsu Bio Science Inc., Japan.

Hirotsu Bio Science employs the world’s first biological diagnostic technology based on the olfaction of nematodes to offer a practical and high-sensitivity multi-cancer early detection test.
Hirotsu Bio Science developed and launched the world’s first pancreatic cancer early detection test with high sensitivity and high specificity, noninvasive (based on urine).

Activities

Collapse all

Hirotsu Bio Science: Tokyo, JP

2022-10-14 to present | Executive officer / Chief Technology Officer (CTO)

Employment

Eric di Luccio

https://orcid.org/0000-0002-2256-2157

Personal information

Websites & social links

Other IDs

Keywords

Countries

Biography

Activities

Employment (6)

Hirotsu Bio Science: Tokyo, JP

Hirotsu Bio Science: Tokyo, Tokyo, JP

Kyungpook National University: Daegu, Daegu, KR

Kyungpook National University: Daegu, Daegu, KR

University of California Davis: Davis, CA, US

University of California Davis: Davis, CA, US

Education and qualifications (4)

Aix-Marseille Universite Ecole Doctorale des Sciences de la Vie et de la Sante: Marseille, Provence-Alpes-Côte d'Azur, FR

Aix-Marseille Universite Ecole Doctorale des Sciences de la Vie et de la Sante: Marseille, Provence-Alpes-Côte d'Azur, FR

Université de Limoges Faculté des Sciences et Techniques: Limoges, FR

Université de Limoges Faculté de Médecine: Limoges, FR

Funding (7)

Role of Set7 in Schizosaccharomyces pombe gametogenesis Implication in human infertility

Static and dynamic crystal lographic investigations for developing specific and selective inhibitors for the epigenetic therapy of cancers

Structural Biology of oncogenic HMTases

LEM-07, inhibitor of NSD2/MMMSET

LEM-07, inhibitor of NSD2/MMMSET

Epigenetics and cancer prevention by dietary phytochemicals Implications for personalized nutrition

Toward a better understanding of the transcription coactivators mechanisms

Works (50 of 69)

Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics

Advancing Veterinary Oncology: Next-Generation Diagnostics for Early Cancer Detection and Clinical Implementation

Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine

Overcoming Challenges in Cancer Care: A Focus on Emerging Technologies

N-NOSE Proves Effective for Early Cancer Detection: Real-World Data from Third-Party Medical Institutions

A non-invasive screening method using Caenorhabditis elegans for early detection of multiple cancer types: A prospective clinical study

Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications

Structural insights into the C-terminus of the histone-lysine N-methyltransferase NSD3 by small-angle X-ray scattering

State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan

Pancreatic Cancer and Detection Methods

Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study

A new detection method for canine and feline cancer using the olfactory system of nematodes

Pancreatic Cancer Research beyond DNA Mutations

C. elegans as a Powerful Tool for Cancer Screening

Nematode-Applied Technology for Human Tumor Microenvironment Research and Development

High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag

Set7 Is a H3K37 Methyltransferase in Schizosaccharomyces pombe and Is Required for Proper Gametogenesis

Identification of LEM-14 inhibitor of the oncoprotein NSD2

Crystal structure of Set7, a novel histone methyltransferase in Schizossacharomyces pombe

Crystal structure of Set7, a novel histone methyltransferase in Schizossacharomyces pombe

BIX-01294 inhibits oncoproteins NSD1, NSD2 and NSD3

Abstract 1377: Set7 is a novel histone methyltransferase inSchizosaccharomyces Pombe

Abstract 5070: Structure-function studies and drug design on the human histone lysine methyltransferases NSD1, NSD2 and NSD3

Cloning, expression, purification and crystallization of Schizosaccharomyces pombe Set7, a putative histone methyltransferase

Structure of the thermophilic l-Arabinose isomerase from Geobacillus kaustophilus reveals metal-mediated intersubunit interactions for activity and thermostability

The structural basis of substrate promiscuity in UDP-hexose 4-epimerase from the hyperthermophilic Eubacterium Thermotoga maritima

NOVEL HISTONE METHYL TRANSFERASE INHIBITOR AND USE THEREOF

Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1, and NSD3/WHSC1L

Crystallographic observation of pH-induced conformational changes in the Amyelois transitella pheromone-binding protein AtraPBP1.

Abstract 676: Substrate specificity and inhibitors of histone lysine HMTase NSD1, NSD2/MMSET/WHSC1, and NSD3/WHSC1L1.

Structure of Pheromone-binding protein 1 in complex with (11Z,13Z)-hexadecadienal

Structure of Pheromone-binding protein 1 in complex with (Z,Z)-11,13- hexadecadienol

The H-factor as a novel quality metric for homology modeling.

Abstract 1060: Structural insights into the regulation and the recognition of histone marks by the SET domain of histone lysine HMTase NSD1, NSD2/MMSET/WHSC1, and NSD3/WHSC1L1

Structural Insights into the Regulation and the Recognition of Histone Marks by the Set Domain of NSD1

A quality metric for homology modeling: the H-factor.

Cancers and the NSD family of histone lysine methyltransferases.

Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1.

Nrf2-mediated induction of phase 2 detoxifying enzymes by glyceollins derived from soybean exposed to Aspergillus sojae.

Effect of cu<sup>2+</sup> on the Oxidative Folding of Synthetic Maurotoxin In Vitro

Comprehensive X-ray structural studies of the quinolinate phosphoribosyl transferase (BNA6) from Saccharomyces cerevisiae.

Crystal structure of the quinolinate phosphoribosyl transferase (BNA6) from Saccharomyces cerevisiae complexed with PRPP

Crystal structure of the quinolinate phosphoribosyl transferase (BNA6) from Saccharomyces cerevisiae complexed with PRPP and the inhibitor phthalate

Crystal structure of the quinolinate phosphoribosyl transferase (BNA6) from Sachharomyces cerevisiae complexed with the inhibitor phthalate

Crystal structure at 1.9A of the apo quinolinate phosphoribosyl transferase (BNA6) from Saccharomyces cerevisiae

Crystal structure of the quinolinate phosphoribosyl transferase (BNA6) from Sachharomyces cerevisiae complexed with quinolinate

Structural and kinetic studies of induced fit in xylulose kinase from Escherichia coli.

Cryo-electron microscopy analysis of a 105 kDa protein particle: The xylulose kinase from E. Coli